OTC Triptans in Pakistan

July 2013 | 14 pages | ID: OE4D152B86FEN
Euromonitor International Ltd

Abstracts

Whilst the prevalence of headaches is on an increase, the case of migraine or combination headaches is relatively lower in Pakistan. Furthermore, OTC triptans are usually not to be consumed for mild headaches. Even in cases of severe headaches most consumers are used to doubling their dosage to two tablets or using a fortified version of a painkiller such as Panadol Extra instead of Panadol. Hence OTC triptans continues to have a negligible market in Pakistan.

Euromonitor International's OTC Triptans in Pakistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the OTC Triptans market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

OTC TRIPTANS IN PAKISTAN
Euromonitor International
July 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Executive Summary
Self-medication Drives Consumer Healthcare in 2012
Vitamins and Dietary Supplements Lead Growth in Consumer Healthcare
Change Seen in Consumption of Herbal Medications
International Manufacturers Face Increasing Costs of Raw Materials
Moderate Growth Expected Over the Forecast Period
Key Trends and Developments
Regulatory Bureaucracy Dampens Manufacturer Spirit To Launch New Products
Non-medicated Products Overtake Sales of OTC Products
Increased Initiative for Awareness-based Campaigns
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Market Data
  Table 2 Sales of Consumer Health by Category: Value 2007-2012
  Table 3 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 4 Consumer Health Company Shares 2008-2012
  Table 5 Consumer Health Brand Shares 2009-2012
  Table 6 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 7 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 8 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 9 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Definitions
Sources
Summary 1 Research Sources